Class 4 Caution in use- Concerta XL tablets 18 &36mg

Recalls and Alerts

Class 4 Caution in Use

Class 4 Caution in use- Concerta XL tablets 18 &36mg

Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.

MHRA drug alert date: 26th February 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-orifarm-uk-ltd-concerta-xl-18mg-and-36-mg-prolonged-release-tablets-el-24-a-slash-07?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a2016e58-88b6-4a8d-a1aa-ce9f9fa4bb23&utm_content=immediately

Pip code	Product	Supplier	Affected Batches
8436313	P.I CONCERTA XL TAB 18MG	Orifarm UK	3EE35801 3EE35802 3EE36101 3EE35803 3EE36102 3FE46100 3FE46101 3GE51900
8436370	P.I CONCERTA XL TAB 36MG	Orifarm UK	3AE07102 3GE50002 3DE29500 3FE44101 3FE44102 3AE07103 3DE29201 3DE29501 3FE44103 3FE46800 3FE46801 3EE37002

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control queries please email jacook@Orifarm.com, or telephone 01923 204333.